Landscape of official development assistance for nutrition data and information systems.


Journal

BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275

Informations de publication

Date de publication:
03 2022
Historique:
received: 09 09 2021
accepted: 23 01 2022
entrez: 9 3 2022
pubmed: 10 3 2022
medline: 26 4 2022
Statut: ppublish

Résumé

Nutrition data and information systems (ND&IS) are critical to guide the prioritisation, collection, analysis and dissemination of nutrition data in countries. However, there is limited guidance for countries regarding how to invest in their ND&IS and little is known about current financing allocations by both countries and donors. This hinders our ability to identify the most critical funding gaps and to effectively advocate for increased financial commitments to ND&IS. To better characterise donor investments, we conducted a review of Official Development Assistance (ODA) financing for ND&IS between the years 2017 and 2019. The analysis showed overall donor financing for ND&IS is not trending up between 2017 and 2019 with the majority of funding being channelled through multilateral organisations to the health sector and spent on global initiatives and emergency early warning system and surveillance activities. Given these findings, donors should dedicate at least 5% (4%-6%) of nutrition investments, alongside country governments, to support country capacity building and strengthening of ND&IS. Donors should also consider channelling a larger part of ODA for ND&IS activities through public institutions to build their capacity to manage ND&IS strengthening.

Identifiants

pubmed: 35260392
pii: bmjgh-2021-007370
doi: 10.1136/bmjgh-2021-007370
pmc: PMC8905917
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Gates Open Res. 2020 Jun 16;4:60
pubmed: 33163903

Auteurs

Alexandra Farina (A)

Results for Development Institute, Washington, District of Columbia, USA.

Yashodhara Rana (Y)

Results for Development Institute, Washington, District of Columbia, USA yrana@r4d.org.

Augustin Flory (A)

Results for Development Institute, Washington, District of Columbia, USA.

Kyle Borces (K)

ThinkWell, Washington, District of Columbia, USA.

Caroline Snead (C)

Independent Researcher, Los Angeles, California, USA.

Rebecca Heidkamp (R)

International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH